Literature DB >> 8497046

Endogenous expression of E1A in human cells enhances the effect of adenovirus E3 on class I major histocompatibility complex antigen expression.

J M Routes1, B A Metz, J L Cook.   

Abstract

Group C human adenovirus (Ad) serotypes (e.g., Ad type 2 [Ad2] and Ad5) cause persistent infections in humans. One explanation for Ad persistence is an ineffective cytotoxic T-lymphocyte response due to diminished cell surface expression of class I major histocompatibility antigen (MHC Ag) on Ad-infected cells, an effect mediated by the Ad E3 19-kDa glycoprotein (E3 effect). However, we previously reported that, except for the Ad5 E1-transformed human cell line 293, a variety of human lymphoid, epithelial, and fibroblastic cells are resistant to the E3 effect during Ad5 infection (J. M. Routes and J. L. Cook, J. Immunol. 144:2763-2770, 1990). The present study tested the hypothesis that endogenous expression of E1A proteins in 293 cells sensitizes cells to this E3 effect, resulting in an enhanced downregulation of surface class I MHC Ag expression following Ad5 infection. Human epithelial and fibroblastic cells expressing E1A gene products for at least 72 h exhibited an enhanced E3 effect following Ad5 infection that was independent of baseline levels of surface class I MHC Ag expression and of E1A induction of E3 19-kDa glycoprotein expression. There was a direct correlation between the level of endogenous E1A expressed and the magnitude of the E3 effect. We postulate that the in vivo existence of cells stably expressing either E1A proteins or E1A-like activities in the microenvironment of Ad5 infection provides a reservoir of Ad-infected cells that is relatively protected from the virus-specific cytotoxic T-lymphocyte response, thereby favoring Ad persistence in humans.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8497046      PMCID: PMC237656          DOI: 10.1128/JVI.67.6.3176-3181.1993

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  30 in total

1.  Latent adenovirus infections of the human respiratory tract.

Authors:  A S EVANS
Journal:  Am J Hyg       Date:  1958-05

2.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

3.  Characteristics of a human cell line transformed by DNA from human adenovirus type 5.

Authors:  F L Graham; J Smiley; W C Russell; R Nairn
Journal:  J Gen Virol       Date:  1977-07       Impact factor: 3.891

4.  The virus watch program: a continuing surveillance of viral infections in metropolitan New York families. VI. Observations of adenovirus infections: virus excretion patterns, antibody response, efficiency of surveillance, patterns of infections, and relation to illness.

Authors:  J P Fox; C D Brandt; F E Wassermann; C E Hall; I Spigland; A Kogon; L R Elveback
Journal:  Am J Epidemiol       Date:  1969-01       Impact factor: 4.897

5.  Monoclonal antibodies against two separate alloantigenic sites of HLA-B40.

Authors:  P Parham
Journal:  Immunogenetics       Date:  1981       Impact factor: 2.846

6.  Deletion mutants of adenovirus 2: isolation and initial characterization of virus carrying mutations near the right end of the viral genome.

Authors:  S S Challberg; G Ketner
Journal:  Virology       Date:  1981-10-15       Impact factor: 3.616

7.  Adenovirus infections in patients undergoing bone-marrow transplantation.

Authors:  A F Shields; R C Hackman; K H Fife; L Corey; J D Meyers
Journal:  N Engl J Med       Date:  1985-02-28       Impact factor: 91.245

8.  Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens-new tools for genetic analysis.

Authors:  C J Barnstable; W F Bodmer; G Brown; G Galfre; C Milstein; A F Williams; A Ziegler
Journal:  Cell       Date:  1978-05       Impact factor: 41.582

9.  Adenovirus infection in the immunocompromised patient.

Authors:  J M Zahradnik; M J Spencer; D D Porter
Journal:  Am J Med       Date:  1980-05       Impact factor: 4.965

10.  Isolation of adenovirus type 5 host range deletion mutants defective for transformation of rat embryo cells.

Authors:  N Jones; T Shenk
Journal:  Cell       Date:  1979-07       Impact factor: 41.582

View more
  8 in total

1.  Expression of gp19K increases the persistence of transgene expression from an adenovirus vector in the mouse lung and liver.

Authors:  J T Bruder; T Jie; D L McVey; I Kovesdi
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

2.  Role of p300-family proteins in E1A oncogene induction of cytolytic susceptibility and tumor cell rejection.

Authors:  J L Cook; C K Krantz; B A Routes
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-26       Impact factor: 11.205

3.  Lack of effect of mouse adenovirus type 1 infection on cell surface expression of major histocompatibility complex class I antigens.

Authors:  S C Kring; K R Spindler
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

4.  The role of human adenovirus early region 3 proteins (gp19K, 10.4K, 14.5K, and 14.7K) in a murine pneumonia model.

Authors:  T E Sparer; R A Tripp; D L Dillehay; T W Hermiston; W S Wold; L R Gooding
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

5.  Identification of hexon-specific CD4 and CD8 T-cell epitopes for vaccine and immunotherapy.

Authors:  Ann M Leen; Anne Christin; Mariam Khalil; Heidi Weiss; Adrian P Gee; Malcolm K Brenner; Helen E Heslop; Cliona M Rooney; Catherine M Bollard
Journal:  J Virol       Date:  2007-10-17       Impact factor: 5.103

6.  Adenovirus-pulsed dendritic cells stimulate human virus-specific T-cell responses in vitro.

Authors:  C A Smith; L S Woodruff; G R Kitchingman; C M Rooney
Journal:  J Virol       Date:  1996-10       Impact factor: 5.103

7.  Prolonged survival of pancreatic islet allografts mediated by adenovirus immunoregulatory transgenes.

Authors:  S Efrat; G Fejer; M Brownlee; M S Horwitz
Journal:  Proc Natl Acad Sci U S A       Date:  1995-07-18       Impact factor: 11.205

8.  Oncogenicity of human papillomavirus- or adenovirus-transformed cells correlates with resistance to lysis by natural killer cells.

Authors:  J M Routes; S Ryan
Journal:  J Virol       Date:  1995-12       Impact factor: 5.103

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.